Atellica IM PTH 10995622Recalls & reported problems
Siemens Healthcare Diagnostics Inc. · Intact Parathyroid Hormone (iPTH) Atellica IM - RGT 950T · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00630414599458), received between Mar 25, 2020 and Jan 17, 2024 — classified as 5 malfunctions.
The most frequently reported specific device problem is “High Test Results” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- High Test Results4
- No Apparent Adverse Event1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 17, 2024High Test Results; High Test Results
THE CUSTOMER REPORTED AN OBSERVATION OF DISCORDANT ELEVATED INTACT PARATHYROID HORMONE (PTH) RESULTS ON MULTIPLE PATIENT(S) SAMPLES ON ATELLICA IM 1600 ANALYZER. THE INITIAL RESULTS WERE REPORTED TO THE PHYSICIAN(S), WHO DID NOT QUESTION THE RESULTS. ALL THE SAMPLES WERE REPEATED ON ALTERNATE ATELLICA IM 1600 ANALYZERS AND THE RESULTS WERE LOWER COMPARED TO THE INITIAL RESULTS. THESE RESULTS WERE CONSIDERED AS CORRECT RESULTS BY THE PHYSICIAN(S). A CORRECTED REPORT WAS ISSUED. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THIS ISSUE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18530630 ↗MalfunctionJan 17, 2024High Test Results; High Test Results
THE CUSTOMER REPORTED AN OBSERVATION OF A DISCORDANT ELEVATED INTACT PARATHYROID HORMONE (PTH) RESULT ON A PATIENT SAMPLE ON ATELLICA IM 1600 ANALYZER. THE INITIAL RESULT WAS REPORTED TO THE PHYSICIAN(S), WHO DID NOT QUESTION THE RESULT. THIS SAMPLE WAS REPEATED ON AN ALTERNATE ATELLICA IM 1600 ANALYZER AND THE RESULT WAS LOWER COMPARED TO THE INITIAL RESULT. THIS RESULT WAS CONSIDERED AS THE CORRECT RESULT BY THE PHYSICIAN(S). A CORRECTED REPORT WAS ISSUED. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THIS ISSUE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18530426 ↗MalfunctionJan 17, 2024High Test Results; High Test Results
THE CUSTOMER REPORTED AN OBSERVATION OF DISCORDANT ELEVATED INTACT PARATHYROID HORMONE (PTH) RESULTS ON MULTIPLE PATIENT(S) SAMPLES ON ATELLICA IM 1600 ANALYZER. THE INITIAL RESULTS WERE REPORTED TO THE PHYSICIAN(S), WHO DID NOT QUESTION THE RESULTS. ALL THE SAMPLES WERE REPEATED ON ALTERNATE ATELLICA IM 1600 ANALYZERS AND THE RESULTS WERE LOWER COMPARED TO THE INITIAL RESULTS. THESE RESULTS WERE CONSIDERED AS CORRECT RESULTS BY THE PHYSICIAN(S). A CORRECTED REPORT WAS ISSUED. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THIS ISSUE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18530403 ↗MalfunctionJan 17, 2024High Test Results; High Test Results
THE CUSTOMER REPORTED AN OBSERVATION OF DISCORDANT ELEVATED INTACT PARATHYROID HORMONE (PTH) RESULTS ON MULTIPLE PATIENT(S) SAMPLES ON ATELLICA IM 1600 ANALYZER. THE INITIAL RESULTS WERE REPORTED TO THE PHYSICIAN(S), WHO DID NOT QUESTION THE RESULTS. ALL THE SAMPLES WERE REPEATED ON ALTERNATE ATELLICA IM 1600 ANALYZERS AND THE RESULTS WERE LOWER COMPARED TO THE INITIAL RESULTS. THESE RESULTS WERE CONSIDERED AS CORRECT RESULTS BY THE PHYSICIAN(S). A CORRECTED REPORT WAS ISSUED. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THIS ISSUE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18530121 ↗MalfunctionMar 25, 2020No Apparent Adverse Event; No Apparent Adverse Event
A DISCORDANT LOW RESULT WAS OBSERVED ON AN ATELLICA IM INTACT PARATHYROID HORMONE (PTH) SAMPLE THAT HAD BEEN PREVIOUSLY FROZEN AT -24 C. THE SAMPLE WAS REPEATED THE FOLLOWING DAY AFTER CENTRIFUGATION RESULTING HIGHER. THE HIGHER RESULT WAS REPORTED TO THE PHYSICIAN(S) AS THE CORRECT RESULT. PATIENT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THE DISCORDANT PTH RESULT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9878861 ↗
Other RADIOIMMUNOASSAY, PARATHYROID HORMONE devices
- VITROS 6802892Ortho Clinical Diagnostics · RADIOIMMUNOASSAY, PARATHYROID HORMONE1 recall155 reports
- Access Intact PTH A16972Beckman Coulter, Inc. · Radioimmunoassay, Parathyroid Hormone2 recalls8 reports
- IMMULITE® 2000 Systems IPT Intact PTH 10381441Siemens Healthcare Diagnostics Products Ltd · RADIOIMMUNOASSAY, PARATHYROID HORMONE1 recall18 reports
- Future Diagnostics 4K-IPT-00Future Diagnostics Solutions B.V. · RADIOIMMUNOASSAY, PARATHYROID HORMONE1 recall0 reports
- IMMULITE® 2000 Systems IPT Intact PTH 10381442Siemens Healthcare Diagnostics Products Ltd · RADIOIMMUNOASSAY, PARATHYROID HORMONE1 recall0 reports
- ADVIA Centaur® iPTH 10492368Siemens Healthcare Diagnostics Inc. · RADIOIMMUNOASSAY, PARATHYROID HORMONE23 reports
- Elecsys PTH 07251068190Roche Diagnostics GmbH · RADIOIMMUNOASSAY, PARATHYROID HORMONE21 reports
- VITROS 6900052Ortho Clinical Diagnostics · RADIOIMMUNOASSAY, PARATHYROID HORMONE21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page